Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
Más filtros

Medicinas Complementárias
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Br J Haematol ; 195(3): 352-364, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-33987825

RESUMEN

T-cell lymphomas (TCLs) constitute a rare subset of non-Hodgkin lymphomas, with mycosis fungoides/Sézary syndrome (MF/SS) being the most common subtype of cutaneous TCLs (CTCLs). Considered an incurable but treatable disease, MF/SS management presents several challenges including diagnostic delays, debilitating effect on patients' quality of life, need for several lines of therapies, multidisciplinary care and cumulative drug toxicities limiting duration of use. The present review intends to provide an overview of the recent advances in our understanding of the biology of CTCL and how these are being leveraged to provide additional treatment options for management of advanced and recurrent disease. In addition, the discussion of the different modalities of treatment is summarised to further outline the importance of multidisciplinary care and early referral to CTCL centres.


Asunto(s)
Micosis Fungoide/terapia , Síndrome de Sézary/terapia , Neoplasias Cutáneas/terapia , Corticoesteroides/uso terapéutico , Anciano , Anticuerpos Monoclonales/uso terapéutico , Antineoplásicos/uso terapéutico , Bexaroteno/uso terapéutico , Biomarcadores de Tumor/sangre , Ensayos Clínicos como Asunto , Terapia Combinada , Diagnóstico Tardío , Diagnóstico Diferencial , Electrones/uso terapéutico , Trasplante de Células Madre Hematopoyéticas , Inhibidores de Histona Desacetilasas/uso terapéutico , Humanos , Interferón-alfa/uso terapéutico , Masculino , Micosis Fungoide/diagnóstico , Micosis Fungoide/patología , Micosis Fungoide/fisiopatología , Estadificación de Neoplasias , Células Madre Neoplásicas/química , Células Madre Neoplásicas/patología , Terapia PUVA , Fotoféresis , Pronóstico , Retinoides/uso terapéutico , Síndrome de Sézary/diagnóstico , Síndrome de Sézary/patología , Síndrome de Sézary/fisiopatología , Transducción de Señal , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología , Subgrupos de Linfocitos T/química , Subgrupos de Linfocitos T/patología
2.
Sci Data ; 8(1): 34, 2021 01 28.
Artículo en Inglés | MEDLINE | ID: mdl-33510154

RESUMEN

Prior skin image datasets have not addressed patient-level information obtained from multiple skin lesions from the same patient. Though artificial intelligence classification algorithms have achieved expert-level performance in controlled studies examining single images, in practice dermatologists base their judgment holistically from multiple lesions on the same patient. The 2020 SIIM-ISIC Melanoma Classification challenge dataset described herein was constructed to address this discrepancy between prior challenges and clinical practice, providing for each image in the dataset an identifier allowing lesions from the same patient to be mapped to one another. This patient-level contextual information is frequently used by clinicians to diagnose melanoma and is especially useful in ruling out false positives in patients with many atypical nevi. The dataset represents 2,056 patients (20.8% with at least one melanoma, 79.2% with zero melanomas) from three continents with an average of 16 lesions per patient, consisting of 33,126 dermoscopic images and 584 (1.8%) histopathologically confirmed melanomas compared with benign melanoma mimickers.


Asunto(s)
Melanoma , Neoplasias Cutáneas , Inteligencia Artificial , Humanos , Melanoma/diagnóstico por imagen , Melanoma/patología , Melanoma/fisiopatología , Metadatos , Piel/patología , Neoplasias Cutáneas/diagnóstico por imagen , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología
3.
Mol Biol Rep ; 47(11): 9021-9032, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33034883

RESUMEN

Despite the depth of knowledge concerning the pathogenesis of melanoma, the most aggressive type of skin cancer, the prognosis and survival of patients still remain a challenge. In addition, responses to chemotherapy and immunotherapy are still poor, which underscore an urgent need in the development of new therapeutic strategies for the treatment of melanoma. Recently, the dynamic role of autophagy has gained considerable interest in the pathogenesis and treatment of melanoma. Whereas a decrease in autophagy activity promotes melanoma formation by increasing oncogene-induced tumorigenesis and DNA damage accumulation, an enhanced level of autophagy sustains melanoma cell viability and contributes to drug resistance. Obviously, the understanding of autophagy regulation may lead to a better defining melanoma pathogenesis and the progression toward new treatment options. In this review, we present new insights into a dual role of autophagy during melanoma tumorigenesis. In addition to summarizing current therapeutics for treating melanoma, we discuss how autophagy manipulation may improve the patients' outcome. Finally, autophagy-modulating drugs and nanoparticles, alone or in combination with current therapeutics, are proposed for possible clinical use in melanoma management.


Asunto(s)
Autofagia/fisiología , Carcinogénesis/efectos de los fármacos , Melanoma/tratamiento farmacológico , Neoplasias Cutáneas/tratamiento farmacológico , Sorafenib/uso terapéutico , Animales , Antineoplásicos/farmacología , Autofagia/efectos de los fármacos , Autofagia/genética , Proteína 5 Relacionada con la Autofagia/genética , Carcinogénesis/genética , Expresión Génica/efectos de los fármacos , Humanos , Melanoma/genética , Melanoma/fisiopatología , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/fisiopatología
4.
Complement Ther Med ; 38: 7-10, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-29857883

RESUMEN

BACKGROUND: Malignant melanoma is a cancer that arises from pigment cells in the skin called melanocytes. The long-term survival of a patient with advanced melanoma is rare. CASE: We present a unique case of a female patient who has suffered from malignant melanoma for more than 13 years. The disease progressed quickly, and 19 months after diagnosis, the patient was classified as having stage IV melanoma. After several years, the patient had several episodes of fever that were not deliberately treated with medication. After each episode of fever, the patient observed the disappearance of tumours, which was confirmed by medical examination. Interestingly, since her initial diagnosis, the patient has refused most of the proposed medical treatments. Consequently, only some of the surgical procedures were performed. Currently, despite the initially poor prognosis, the patient only suffers symptoms that are the result of surgical resection of brain metastases. Most of her malignant tumours either disappeared or have stabilized without further growth. CONCLUSIONS: The onset of fever has altered the typical and unfavourable course of melanoma, causing remission or at least stabilization. This observation, in accordance with others in this field, suggests that fever in cancer patients should not be treated immediately, but should be allowed to develop under the care of a physician.


Asunto(s)
Neoplasias Encefálicas , Fiebre , Melanoma , Regresión Neoplásica Espontánea , Neoplasias Cutáneas , Adulto , Neoplasias Encefálicas/fisiopatología , Neoplasias Encefálicas/secundario , Femenino , Humanos , Gripe Humana , Melanoma/patología , Melanoma/fisiopatología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología
5.
BMC Complement Altern Med ; 17(1): 36, 2017 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-28073348

RESUMEN

BACKGROUND: Previous studies in our laboratory showed that the Lebanese Daucus carota ssp. carota (wild carrot) oil extract possesses in vitro and in vivo anticancer activities. The present study aims to examine the cytotoxic effect of Daucus carota oil fractions on human epidermal keratinocytes and evaluate the chemopreventive activity of the pentane diethyl ether fraction on DMBA/TPA induced skin carcinogenesis in mice. METHODS: Wild carrot oil extract was chromatographed to yield four fractions (F1, 100% pentane; F2, 50:50 pentane:diethyl ether; F3, 100% diethyl ether; F4 93:7 chloroform:methanol). The cytotoxic effect of fractions (10, 25, 50 and 100 µg/mL) was tested on human epidermal keratinocytes (non-tumorigenic HaCaT cells and tumorigenic HaCaT-ras variants) using WST a ssay. Cell cycle phase distribution of tumorigenic HaCaT-ras variants was determined by flow cytometry post-treatment with F2 fraction. Apoptosis related proteins were also assessed using western blot. The antitumor activity of F2 fraction was also evaluated using a DMBA/TPA induced skin carcinoma in Balb/c mice. RESULTS: All fractions exhibited significant cytotoxicity, with HaCaT cells being 2.4-3 times less sensitive than HaCaT-ras A5 (benign tumorigenic), and HaCaT-ras II4 (malignant) cells. GC-MS analysis revealed the presence of a major compound (around 60%) in the pentane/diethylether fraction (F2), identified as 2-himachalen-6-ol. Treatment of HaCaT-ras A5 and HaCaT-ras II4 cells with F2 fraction resulted in the accumulation of cells in the sub-G1 apoptotic phase and decreased the population of cells in the S and G2/M phases. Additionally, F2 fraction treatment caused an up-regulation of the expression of pro-apoptotic (Bax) and down-regulation of the expression of anti-apoptotic (Bcl2) proteins. A decrease in the phosphorylation of AKT and ERK was also observed. Intraperitoneal treatment with F2 fraction (50 or 200 mg/kg) in the DMBA/TPA skin carcinogenesis mouse model showed a significant inhibition of papilloma incidence (mice with papilloma), yield (number of papilloma/mouse) and volume (tumor relative size) at weeks 15, 18 and 21. CONCLUSION: The present data reveal that F2 fraction has a remarkable antitumor activity against DMBA/TPA-induced skin carcinogenesis, an effect that may be mediated through inhibition of the MAPK/ERK and PI3K/AKT pathways.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Daucus carota/química , Queratinocitos/citología , Sustancias Protectoras/administración & dosificación , Neoplasias Cutáneas/prevención & control , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Apoptosis/efectos de los fármacos , Ciclina D1/genética , Ciclina D1/metabolismo , Fase G1/efectos de los fármacos , Humanos , Queratinocitos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/fisiopatología , Acetato de Tetradecanoilforbol/toxicidad , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
6.
Photochem Photobiol ; 93(1): 296-303, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27861965

RESUMEN

The skin is in constant exposure to various external environmental stressors, including solar ultraviolet (UV) radiation. Various wavelengths of UV light are absorbed by the DNA and other molecules in the skin to cause DNA damage and induce oxidative stress. The exposure to excessive ultraviolet (UV) radiation and/or accumulation of damage over time can lead to photocarcinogenesis and photoaging. The nucleotide excision repair (NER) system is the sole mechanism for removing UV photoproduct damage from DNA, and genetic disruption of this repair pathway leads to the photosensitive disorder xeroderma pigmentosum (XP). Interestingly, recent work has shown that NER is controlled by the circadian clock, the body's natural time-keeping mechanism, through regulation of the rate-limiting repair factor xeroderma pigmentosum group A (XPA). Studies have shown reduced UV-induced skin cancer after UV exposure in the evening compared to the morning, which corresponds with times of high and low repair capacities, respectively. However, most studies of the circadian clock-NER connection have utilized murine models, and it is therefore important to translate these findings to humans to improve skin cancer prevention and chronotherapy.


Asunto(s)
Ritmo Circadiano , Daño del ADN , Reparación del ADN , Neoplasias Inducidas por Radiación/fisiopatología , Neoplasias Cutáneas/etiología , Rayos Ultravioleta , Animales , Humanos , Neoplasias Inducidas por Radiación/metabolismo , Estrés Oxidativo , Piel/metabolismo , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/fisiopatología , Proteína de la Xerodermia Pigmentosa del Grupo A/metabolismo
8.
BMC Complement Altern Med ; 15: 445, 2015 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-26694191

RESUMEN

BACKGROUND: Melanoma is an aggressive skin cancer and a predominant cause of skin cancer-related deaths. A previous study has demonstrated the ability of butein to inhibit tumor proliferation and invasion. However, the anti-metastatic mechanisms and in vivo effects of butein have not been fully elucidated. METHODS: MTT cell viability assays were used to evaluate the antitumor effects of butein in vitro. Cytotoxic effects of butein were measured by lactate dehydrogenase assay. Anti-migratory effects of butein were evaluated by two-dimensional scratch and transwell migration assays. Signaling transduction and VEGF-releasing assays were measured by Western blotting and ELISA. We also conducted an experimental analysis of the metastatic potential of tumor cells injected into the tail vein of C57BL/6 mice. RESULTS: We first demonstrated the effect of butein on cell viability at non-cytotoxic concentrations (1, 3, and 10 µM). In vitro, butein was found to inhibit the migration of B16F10 cells in a concentration-dependent manner using transwell and scratch assays. Butein had a dose-dependent effect on focal adhesion kinase, Akt, and ERK phosphorylation in B16F10 cells. Butein efficiently inhibited the mTOR/p70S6K translational inhibition machinery and decreased the production of VEGF in B16F10 cells. Furthermore, the in vivo antitumor effects of butein were demonstrated using a pulmonary metastasis model. CONCLUSION: The results of the present study indicate the potential utility of butein in the treatment of melanoma.


Asunto(s)
Chalconas/administración & dosificación , Melanoma Experimental/tratamiento farmacológico , Neoplasias Cutáneas/tratamiento farmacológico , Factor A de Crecimiento Endotelial Vascular/metabolismo , Animales , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Humanos , Masculino , Melanoma Experimental/metabolismo , Melanoma Experimental/patología , Melanoma Experimental/fisiopatología , Ratones , Ratones Endogámicos C57BL , Metástasis de la Neoplasia , Transducción de Señal/efectos de los fármacos , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología , Factor A de Crecimiento Endotelial Vascular/genética
9.
J Dtsch Dermatol Ges ; 13(2): 118-24, 2015 Feb.
Artículo en Inglés, Alemán | MEDLINE | ID: mdl-25631128

RESUMEN

The cancer stem cell concept significantly broadens our understanding of melanoma biology. However, this concept should be regarded as an integral part of a holistic cancer model that also includes the genetic evolution of tumor cells and the variability of cell phenotypes within a dynamic tumor microenvironment. The biologic complexity and methodological difficulties in identifying cancer stem cells and their biomarkers are currently impeding the direct translation of experimental findings into clinical practice. Nevertheless, it is these methodological shortcomings that provide a new perspective on the phenotypic heterogeneity and plasticity of melanoma with important consequences for future therapies. The development of new combination treatment strategies, particularly with regard to overcoming treatment resistance, could significantly benefit from targeted elimination of cell subpopulations with cancer stem cell properties.


Asunto(s)
Melanoma/patología , Melanoma/fisiopatología , Células Madre Neoplásicas/patología , Células Madre Neoplásicas/fisiología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología , Animales , Antineoplásicos/uso terapéutico , Biomarcadores de Tumor/análisis , Transformación Celular Neoplásica/efectos de los fármacos , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/patología , Resistencia a Antineoplásicos , Humanos , Melanoma/tratamiento farmacológico , Melanoma/genética , Células Madre Neoplásicas/efectos de los fármacos , Fenotipo , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/genética , Investigación Biomédica Traslacional
10.
J Neurooncol ; 120(1): 103-9, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25022450

RESUMEN

NF1, NF2, and Schwannomatosis are incurable tumor suppressor syndromes associated with poor quality of life. The aim of this study was to determine the feasibility, acceptability, and preliminary efficacy of an NF adapted, 8-week group mind body skills based intervention, the relaxation response resiliency program (3RP) aimed at improving resiliency and increasing satisfaction with life. Patients seen at MGH's Neurofibromatosis Clinic were offered participation if they described difficulties coping to a treating physician. Participants completed measures of life satisfaction, resiliency, stress, mood, lifestyle, pain, post-traumatic growth and mindfulness at baseline and after completing the 3RP program. The intervention had relative feasible enrollment rate (48% rate, 32 out of 67 of patients signing the informed consent form). However, out of the 32 patients who signed the informed consent, only 20 started the study (62.5%) and only 16 completed it (50%), suggesting problems with feasibility. The main reason cited for non-participation was burden of travel to the clinic. The intervention was highly acceptable, as evidenced by an 80% completion rate (16/20). Paired t tests showed significant improvement in resiliency, satisfaction with life, depression, stress, anxiety, mindfulness and post traumatic growth, with effect sizes ranging from 0.73-1.33. There was a trend for significance for improvement in somatization and sleepiness (p = 0.06), with effect sizes of 0.54-0.92 respectively. Statistically nonsignificant improvement was observed in all other measures, with effect sizes small to medium. In sum, the 3RP was found to be relatively feasible, highly acceptable and preliminary efficacious in decreasing symptom burden in this population, supporting the need of a randomized controlled trial.


Asunto(s)
Terapias Mente-Cuerpo/métodos , Neurilemoma/terapia , Neurofibromatosis/terapia , Neurofibromatosis 1/terapia , Neurofibromatosis 2/terapia , Relajación/fisiología , Resiliencia Psicológica , Neoplasias Cutáneas/terapia , Estrés Psicológico/terapia , Adaptación Psicológica , Estudios de Factibilidad , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Atención Plena , Neurilemoma/fisiopatología , Neurofibromatosis/fisiopatología , Neurofibromatosis 1/fisiopatología , Neurofibromatosis 2/fisiopatología , Atención Dirigida al Paciente , Proyectos Piloto , Pronóstico , Calidad de Vida , Neoplasias Cutáneas/fisiopatología , Estrés Psicológico/fisiopatología
11.
Food Funct ; 5(2): 257-64, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24258363

RESUMEN

Our previous data showed that the Momordica grosvenori Swingle extract (MSE) exhibited the anti-inflammatory effect through markedly suppressed LPS-induced up-regulation of inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2) and ODC (ornithine decarboxylase) gene expression in RAW 264.7 cells. Regarding the link between inflammation and carcinogenesis, we further investigated the bio-molecular mechanisms of both anti-inflammatory and anti-tumor activities in vivo using a TPA (12-O-tetradecanoyl phorbol 13-acetate)-stimulated mouse skin model. Pretreatment with MSE in mouse skin has led to the reduction of TPA-induced nuclear translocation of the nuclear factor-κB (NFκB) subunits as well as phosphorylation of IκBα and p65 subsequent reduction of IκBα degradation. In addition, the MSE inhibitory effect on upstream of NFκB was found to involve the transcriptional effects of MAPK signaling as indicated by strong suppression on TPA-induced activation of extracellular signal regulate kinase (ERK)1/2, p38 mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK)1/2, phosphatidylinositol 3-kinase (PI3K) and Akt. Moreover, MSE significantly inhibited 7,12-dimethylbenz[a]anthracene (DMBA)-TPA-induced skin tumor formation in mice measured by the tumor multiplicity of papillomas at 20 weeks. The results suggested that MSE contained promising functional ingredients capable of preventing inflammation-associated tumorigenesis.


Asunto(s)
Antiinflamatorios/administración & dosificación , Medicamentos Herbarios Chinos/administración & dosificación , Edema/tratamiento farmacológico , Momordica/química , Neoplasias Cutáneas/prevención & control , Piel/inmunología , Animales , Edema/genética , Edema/inmunología , Femenino , Humanos , Técnicas In Vitro , Ratones , FN-kappa B/genética , FN-kappa B/inmunología , Ornitina Descarboxilasa/genética , Ornitina Descarboxilasa/inmunología , Proteínas Proto-Oncogénicas c-akt/genética , Proteínas Proto-Oncogénicas c-akt/inmunología , Piel/efectos de los fármacos , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/fisiopatología , Acetato de Tetradecanoilforbol/efectos adversos
12.
Cutis ; 94(6): 297-300, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25566571

RESUMEN

We report the case of a healthy 17-year-old adolescent boy with an unremarkable medical history who presented with an asymptomatic fixed rash on the abdomen, buttocks, and legs. The rash initially developed in a small area on the right leg 2 years prior and had progressed slowly. Prior biopsies were consistent with pigmented purpura. Clinical examination revealed multiple annular purpuric patches on the abdomen, buttocks, and legs covering approximately 20% of the body surface area without lymphadenopathy or hepatosplenomegaly. Additional biopsies demonstrated changes consistent with mycosis fungoides (MF). T-cell receptor g gene rearrangements demonstrated clonality. The patient was diagnosed with stage IB MF of the pigmented purpura-like variant. The patient responded well to psoralen plus UVA therapy. It has been proposed that pigmented purpuric dermatosis (PPD) is a form of cutaneous T-cell lymphoid dyscrasia and that T-cell gene rearrangement studies should be obtained for prognostic evaluation in patients with widespread disease. In our patient, the clinical appearance of the lesions, pathologic findings, and gene rearrangement studies led to the diagnosis of MF. Until the potential for evolution of PPD to malignant disease is better understood, further evaluation of MF in patients with an unusual presentation of pigmented purpura is warranted.


Asunto(s)
Abdomen/patología , Hiperpigmentación , Pierna/patología , Micosis Fungoide , Terapia PUVA/métodos , Púrpura , Piel/patología , Adolescente , Biopsia , Diagnóstico Diferencial , Genes Codificadores de la Cadena gamma de los Receptores de Linfocito T/genética , Humanos , Hiperpigmentación/diagnóstico , Hiperpigmentación/etiología , Masculino , Micosis Fungoide/complicaciones , Micosis Fungoide/patología , Micosis Fungoide/fisiopatología , Micosis Fungoide/terapia , Estadificación de Neoplasias , Púrpura/diagnóstico , Púrpura/etiología , Neoplasias Cutáneas/complicaciones , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología , Neoplasias Cutáneas/terapia , Linfocitos T/patología , Resultado del Tratamiento
13.
J Sep Sci ; 36(16): 2602-10, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23775831

RESUMEN

Betulinic acid (1), betulinic acid-3-acetate (2), 3-acetylbetulinaldehyde (3), oleanolic acid-3-acetate (4), 3-ß-hydroxy-28,19-ß-olenolide (5), and ß-sitosterol (6) were isolated from Platanus orientalis and a high-performance thin-layer chromatography method was developed for their simultaneous quantification. The markers were first derivatized on the chromatogram with ceric ammonium sulfate and then high-performance thin-layer chromatography densitometry was carried out. Chromatographic separation of these markers was carried out on silica gel 60 plates using a ternary solvent system n-hexane/toluene/acetone (6:3.5:1 v/v/v) as a mobile phase. For marker 1, a deuterium (D2) lamp and wavelength of 420 nm was used. A tungsten (W) lamp was used for markers 2 and 3 at 550 nm and for 4-6 at 500 nm. The method was validated for accuracy, precision, LOD, and LOQ. All calibration curves showed a good linear relationship (r > 0.9919). The precision evaluated by an intra- and interday study showed RSDs < 2.51% and accuracy validation recovery between 95.54 and 99.33% with RSDs < 1.55%. The successful application of the validated method showed 1 as the most abundant component (4.63%) and 5 (0.017%) the least. The markers displayed a significant cytotoxic effect against human keratinocyte, mouse melanoma, and human skin epithelial carcinoma cancer cells by using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.


Asunto(s)
Cromatografía en Capa Delgada/métodos , Magnoliopsida/química , Extractos Vegetales/química , Extractos Vegetales/toxicidad , Neoplasias Cutáneas/tratamiento farmacológico , Animales , Biomarcadores/química , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Humanos , Ratones , Neoplasias Cutáneas/fisiopatología
14.
J Integr Med ; 11(2): 116-24, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23506692

RESUMEN

OBJECTIVE: Preventive measures against skin melanoma like chemotherapy are useful but suffer from chronic side effects and drug resistance. Ethanolic extract of Phytolacca decandra (PD), used in homeopathy for the treatment of various ailments like chronic rheumatism, regular conjunctivitis, psoriasis, and in some skin diseases was tested for its possible anticancer potential. METHODS: Cytotoxicity of the drug was tested by conducting 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay on both normal (peripheral blood mononuclear cells) and A375 cells. Fluorescence microscopic study of 4',6-diamidino-2-phenylindole dihydrochloride-stained cells was conducted for DNA fragmentation assay, and changes in cellular morphology, if any, were also recorded. Lactate dehydrogenase activity assay was done to evaluate the percentages of apoptosis and necrosis. Reactive oxygen species (ROS) accumulation, if any, and expression study of apoptotic genes also were evaluated to pin-point the actual events of apoptosis. RESULTS: Results showed that PD administration caused a remarkable reduction in proliferation of A375 cells, without showing much cytotoxicity on peripheral blood mononuclear cells. Generation of ROS and DNA damage, which made the cancer cells prone to apoptosis, were found to be enhanced in PD-treated cells. These results were duly supported by the analytical data on expression of different cellular and nuclear proteins, as for example, by down-regulation of Akt and Bcl-2, up-regulation of p53, Bax and caspase 3, and an increase in number of cell deaths by apoptosis in A375 cells. CONCLUSION: Overall results demonstrate anticancer potentials of PD on A375 cells through activation of caspase-mediated signaling and ROS generation.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Melanoma/metabolismo , Phytolacca/química , Especies Reactivas de Oxígeno/metabolismo , Neoplasias Cutáneas/metabolismo , Caspasa 3/genética , Caspasa 3/metabolismo , Línea Celular Tumoral , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Melanoma/tratamiento farmacológico , Melanoma/genética , Melanoma/fisiopatología , Fitoterapia , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Transducción de Señal/efectos de los fármacos , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/fisiopatología , Regulación hacia Arriba/efectos de los fármacos
15.
Asia Pac J Clin Nutr ; 22(1): 1-5, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23353604

RESUMEN

The functions of vitamin D are pleiotropic affecting all body organs and systems in some way. Its adequacy depends principally on sunshine for UV light to stimulate its synthesis in skin and on foods which contain it, either animal-derived or obtained from fungi or mushrooms, with the UV-responsive substrates dehydrocholesterol for vitamin D-3 or ergosterol for vitamin D-2, respectively. Thus, vitamin D health is very environmentally dependent. With ecosytem degradation, whether by atmospheric pollution or food systems which do not derive UV irradiation, as with fish farming or mushroom processing, then this nutrient input into human biology may falter. Vitamin D deficiency is now common and widespread in North-East Asia as elsewhere. When discovered early in the 20th century it was linked to rickets in children and osteomalacia in adults and, for a generation or so, children were given fish, usually cod, liver oil to prevent bone disease. Now cod as a species and many edible fish are threatened. Over-exposure to sun-light increases the risk of skin cancer. We may tackle this problem by vitamin D supplementation with an alternative to fish liver. But the demographic pressures of population size and ageing (when the skin is less UV responsive) make the clinical and public health decisions and strategies demanding. Vitamin D health has become indicative of food security whose usual indicator is food diversity; such diversity may allow lesser concentrations to be more effective in organ and system function, but we have little evidence to support this at present.


Asunto(s)
Abastecimiento de Alimentos , Estado Nutricional , Vitamina D/administración & dosificación , Vitamina D/sangre , Asia , Enfermedades Óseas/etiología , Enfermedades Óseas/fisiopatología , Enfermedades Óseas/prevención & control , Interacción Gen-Ambiente , Humanos , Factores de Riesgo , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/fisiopatología , Neoplasias Cutáneas/prevención & control , Luz Solar , Rayos Ultravioleta , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/fisiopatología , Deficiencia de Vitamina D/prevención & control
16.
Food Funct ; 4(2): 338-46, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23175101

RESUMEN

Skin is generally damaged through genetic and environmental factors such as smoking, exposure to xenobiotics, heat, hormonal changes, and ultraviolet light. These factors can cause skin diseases. Cissus quadrangularis Linn. (CQ) has been used in folk medicine for the treatment of skin diseases since ancient times. Taking in to consideration the medicinal properties exhibited by this genus, it was decided to investigate the anti-cancer activity of CQ. Extracts obtained from CQ and their phenolic contents were subjected to in vitro evaluation of anticancer activity by using A431 (skin epidermoid carcinoma, human) cell line. The A431 cells were treated with different extracts of CQ in a dose dependent manner. Out of five extracts, the acetone extract demonstrated significant anti-cancer activity in the A431 cell line. Hexane, chloroform, ethyl acetate and methanol extracts also exhibited cytotoxicity but to a comparatively lesser extent than the acetone extract. The GI(50) value of the acetone extract was found to be 8 µg mL(-1), whereas GI(50) value of purified fraction of acetone extract, termed as AFCQ (active acetone fraction of CQ) with respect to A431 cells, was found to be 4.8 µg mL(-1). Furthermore, the mechanism of anticancer activity exhibited by AFCQ was investigated by comparing its effect with the standard anticancer drug Doxorubicin (DOX) by evaluating the status of apoptotic markers after treatment of A431 cells with AFCQ and DOX. Bax-Bcl-2 ratio along with the release of cytochrome c from mitochondria to cytoplasm, which is a hallmark of apoptosis, was also evaluated. Cleavage of PARP revealed that AFCQ induces apoptosis in A431 cells with reference to DOX.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Cissus/química , Citocromos c/metabolismo , Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Neoplasias Cutáneas/metabolismo , Proteína X Asociada a bcl-2/metabolismo , Línea Celular Tumoral , Humanos , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Extractos Vegetales/farmacología , Tallos de la Planta/química , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/enzimología , Neoplasias Cutáneas/fisiopatología
17.
Pigment Cell Melanoma Res ; 25(5): 618-29, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22686288

RESUMEN

Non-thermal nanoelectroablation therapy completely ablates UV-induced murine melanomas. C57/BL6-HGF/SF transgenic mice were exposed to UV radiation as pups and began to develop visible melanomas 5-6 months later. We have treated 27 of these melanomas in 14 mice with nanosecond pulsed electric field (nsPEF) therapy delivering 2000 electric pulses each 100 ns long and 30 kV/cm at a rate of 5-7 pulses per second. All nanoelectroablated melanoma tumors began to shrink within a day after treatment and gradually disappeared over a period of 12-29 days. Pyknosis of nuclei was evident within 1 h of nsPEF treatment, and DNA fragmentation as detected by TUNEL staining was evident by 6 h after nsPEF treatment. In a melanoma allograft system, nsPEF treatment was superior to tumor excision at accelerating secondary tumor rejection in immune-competent mice, suggesting enhanced stimulation of a protective immune response by nsPEF-treated melanomas. This is supported by the presence of CD4(+) -T cells within treated tumors as well as within untreated tumors located in mice with other melanomas that had been treated with nanoelectroablation at least 19 days earlier.


Asunto(s)
Técnicas de Ablación/métodos , Terapia por Estimulación Eléctrica/métodos , Inmunidad/inmunología , Melanoma/inmunología , Melanoma/terapia , Nanomedicina/métodos , Neoplasias Cutáneas/terapia , Animales , Apoptosis/efectos de la radiación , Linfocitos T CD4-Positivos/inmunología , Etiquetado Corte-Fin in Situ , Melanoma/patología , Melanoma/fisiopatología , Melanoma Experimental/inmunología , Melanoma Experimental/patología , Melanoma Experimental/fisiopatología , Melanoma Experimental/terapia , Ratones , Ratones Endogámicos C57BL , Reproducibilidad de los Resultados , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología , Pigmentación de la Piel/efectos de la radiación , Temperatura , Rayos Ultravioleta
18.
Exp Dermatol ; 20(8): 653-8, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21569101

RESUMEN

Photodynamic therapy was found to be an effective therapy for local malignant tumors. This study demonstrated that 80 µg/ml Hedyotis corymbosa extracts with 0.8 J/cm(2) fluence dose caused M21 skin cancer cell death. Photoactivated H. corymbosa-induced M21 cell death is a typical apoptosis that is accompanied by nuclear condensation, externalization of phosphatidylserine and the changes in protein expression of apoptosis-related proteins, such as Bcl-2 and caspase family members. This study applied 2D electrophoresis to analyse the proteins involved in the photoactivated H. corymbosa-induced M21 cell apoptosis. We found 12 proteins to be markedly changed. According to the results of protein sequence analysis of these altered protein spots, we identified that the expression of cytoskeletal proteins and chaperones were involved in the photoactivated H. corymbosa-induced M21 cell apoptosis. We further demonstrated that photoactivated H. corymbosa caused a significant effect on the cytoskeleton distribution and mitochondrial activity in M21 cells. Based on the above findings, this study characterized the effects and mechanisms of the photoactivated H. corymbosa-induced apoptosis in M21 skin cancer cells.


Asunto(s)
Proteínas del Citoesqueleto/fisiología , Medicamentos Herbarios Chinos/uso terapéutico , Hedyotis , Melanoma/tratamiento farmacológico , Chaperonas Moleculares/fisiología , Fotoquimioterapia , Proteómica , Neoplasias Cutáneas/tratamiento farmacológico , Citoesqueleto de Actina/efectos de los fármacos , Citoesqueleto de Actina/fisiología , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Caspasas/fisiología , Línea Celular Tumoral , Citocromos c/fisiología , Humanos , Melanoma/patología , Melanoma/fisiopatología , Mitocondrias/efectos de los fármacos , Mitocondrias/fisiología , Faloidina/farmacología , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/fisiopatología , Proteína X Asociada a bcl-2/fisiología
19.
J Med Food ; 14(7-8): 761-6, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21470043

RESUMEN

Solar ultraviolet radiation (UV) is the major cause of nonmelanoma skin cancer in humans. Photochemoprevention with natural products represents a simple but very effective strategy for the management of cutaneous neoplasia. We studied the photoprotective activity of Calluna vulgaris and red grape seed (Vitis vinifera L, Burgund Mare variety [BM]) extracts in vivo in an SKH-1 hairless mice skin model. Fifty 8-week-old female SKH-1 hairless mice were randomly divided into 5 groups (n = 10 each): controls, UVB-irradiated, C. vulgaris plus UVB-irradiated, BM plus UVB-irradiated, and epigallocatechin gallate (EGCG) plus UVB-irradiated. A dose of 4 mg/mouse per cm² of skin area for both extracts was topically applied to the mice 30 minutes before a single-dose (240 mJ/cm²) UVB exposure. EGCG dissolved in phosphate-buffered saline (pH 6.6; 0.067 M) was administered at 2 mg/mouse per cm². Glutathione peroxidase and catalase activities, reduced glutathione (GSH), malondialdehyde, nitric oxide, and caspase 3 activity were determined in skin homogenates 24 hours after irradiation. A single dose of UVB increased GSH levels and glutathione peroxidase activity in the exposed skin. C. vulgaris and BM pretreatment significantly decreased GSH formation and glutathione peroxidase activity (P < .001) and inhibited UVB-induced lipid peroxidation (P < .0001) and nitric oxide production (C. vulgaris: P < .06). Topical treatments with C. vulgaris and particularly BM extracts (P < .002) significantly reduced caspase 3 activity, indicating that the cells were protected against apoptosis. These results suggest that C. vulgaris and BM extracts might be chemopreventive candidates for reducing UV-induced risk for skin cancer.


Asunto(s)
Apoptosis/efectos de los fármacos , Calluna/química , Extracto de Semillas de Uva/administración & dosificación , Estrés Oxidativo/efectos de la radiación , Extractos Vegetales/administración & dosificación , Neoplasias Cutáneas/prevención & control , Piel/efectos de los fármacos , Animales , Apoptosis/efectos de la radiación , Modelos Animales de Enfermedad , Femenino , Humanos , Ratones , Ratones Pelados , Sustancias Protectoras/administración & dosificación , Piel/citología , Piel/metabolismo , Piel/efectos de la radiación , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/fisiopatología , Rayos Ultravioleta/efectos adversos
20.
Biosci Biotechnol Biochem ; 75(3): 489-95, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21389613

RESUMEN

The compounds present in rose hips exerting an inhibitory action against melanogenesis in B16 mouse melanoma cells were investigated by dividing an aqueous extract of rose hips (RE) into four fractions. The 50% ethanol eluate from a DIAION HP-20 column significantly reduced the production of melanin and was mainly composed of procyanidin glycosides. We also found that this 50% ethanol eluate reduced the intracellular tyrosinase activity and also had a direct inhibitory effect on tyrosinase obtained as a protein mixture from the melanoma cell lysate. We also investigated the effect of orally administering RE on skin pigmentation in brown guinea pigs, and found that the pigmentation was inhibited together with the tyrosinase activity in the skin. These data collectively suggest that proanthocyanidins from RE inhibited melanogenesis in mouse melanoma cells and guinea pig skin, and could be useful as a skin-whitening agent when taken orally.


Asunto(s)
Melaninas/antagonistas & inhibidores , Melanoma Experimental/tratamiento farmacológico , Monofenol Monooxigenasa/antagonistas & inhibidores , Extractos Vegetales/administración & dosificación , Neoplasias Cutáneas/tratamiento farmacológico , Administración Oral , Animales , Arbutina/farmacología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Etanol/química , Femenino , Glicósidos/farmacología , Glicósidos/uso terapéutico , Cobayas , Melaninas/biosíntesis , Melanoma Experimental/fisiopatología , Ratones , Monofenol Monooxigenasa/metabolismo , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Proantocianidinas/farmacología , Proantocianidinas/uso terapéutico , Rosa/química , Rosa/metabolismo , Piel/efectos de los fármacos , Piel/efectos de la radiación , Neoplasias Cutáneas/fisiopatología , Pigmentación de la Piel/efectos de los fármacos , Pigmentación de la Piel/efectos de la radiación , Rayos Ultravioleta/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA